|
|
| | 8-chloro-1-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione Basic information |
| Product Name: | 8-chloro-1-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione | | Synonyms: | 7-Chloro-5-phenyl-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione;8-chloro-1-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione;7-Chloro-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione;Norclobazam;1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 8-chloro-1-phenyl-;Clofazin;Einecs 244-909-2;N-Demethylclobazam | | CAS: | 22316-55-8 | | MF: | C15H11ClN2O2 | | MW: | 286.71 | | EINECS: | 244-909-2 | | Product Categories: | Aromatics;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals | | Mol File: | 22316-55-8.mol |  |
| | 8-chloro-1-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione Chemical Properties |
| Melting point | >239°C (dec.) | | Boiling point | 601.8±55.0 °C(Predicted) | | density | 1.363±0.06 g/cm3(Predicted) | | Fp | 2℃ | | storage temp. | Controlled Substance, -20°C Freezer | | solubility | Acetonitrile (Soluble) | | form | A neat solid | | pka | 7.57±0.20(Predicted) | | Major Application | clinical testing | | InChI | 1S/C15H11ClN2O2/c16-10-6-7-12-13(8-10)18(11-4-2-1-3-5-11)15(20)9-14(19)17-12/h1-8H,9H2,(H,17,19) | | InChIKey | RRTVVRIFVKKTJK-UHFFFAOYSA-N | | SMILES | O=C(C1)N(C2=CC=CC=C2)C3=C(C=CC(Cl)=C3)NC1=O |
| Hazard Codes | F,Xn | | Risk Statements | 11-20/21/22-36 | | Safety Statements | 16-36/37 | | RIDADR | UN 1648 3 / PGII | | WGK Germany | 2 | | Storage Class | 3 - Flammable liquids | | Hazard Classifications | Acute Tox. 4 Dermal
Acute Tox. 4 Inhalation
Acute Tox. 4 Oral
Eye Irrit. 2
Flam. Liq. 2 | | Toxicity | mouse,LD50,oral,> 2583mg/kg (2583mg/kg),United States Patent Document. Vol. #3760074, |
| | 8-chloro-1-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione Usage And Synthesis |
| Description | N-Desmethylclobazam (CRM) (Item No. 18888) is a certified reference material that is structurally categorized as a benzodiazepine. It is a major active metabolite of clobazam, produced primarily by the action of cytochrome P450 isoform 3A4. N-Desmethylclobazam (CRM) positively modulates GABAA receptors (EC50s range from 98 to 151 μM, depending on subunit configuration). This product is intended for research and forensic applications. | | Description | N-Desmethylclobazam (Item No. 18564) is an analytical reference material that is structurally categorized as a benzodiazepine. It is a major active metabolite of clobazam, produced primarily by the action of cytochrome P450 isoform 3A4. N-Desmethylclobazam positively modulates GABAA receptors (EC50s range from 98 to 151 μM, depending on subunit configuration). This product is intended for research and forensic applications. | | Chemical Properties | Off-White Solid | | Uses | The major metabolite of Clobazam
Controlled substance (depressant). | | Definition | ChEBI: N-Desmethylclobazam is a benzodiazepine. | | General Description | A Certified Solution Standard for use in LC or GC applications from forensic and forensic toxicology analysis to urine drug testing. N-Desmethylclobazam, found in urine, serum, and plasma, is the pharmacologically active, major metabolite of clobazam. | | References | [1] JOSE DE LEON Francisco J D Edoardo Spina. Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.[J]. Therapeutic Drug Monitoring, 2013, 35 1: 30-47. DOI: 10.1097/ftd.0b013e31827ada88
[2] HARRIET HAMMER. Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes.[J]. PLoS ONE, 2015: e0120239. DOI: 10.1371/journal.pone.0120239 |
| | 8-chloro-1-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione Preparation Products And Raw materials |
|